Home - Products - Cell Cycle/DNA Damage - Potassium Channel - Retigabine

Retigabine

CAS No. 150812-12-7

Retigabine( D 23129 | GKE-841 | GW 582892X | WAY-143841 )

Catalog No. M12105 CAS No. 150812-12-7

Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Retigabine
Note

Research use only, not for human use.
Brief Description

Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
Description

Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
In Vitro

——
In Vivo

——
Synonyms

D 23129 | GKE-841 | GW 582892X | WAY-143841
Pathway

Cell Cycle/DNA Damage
Target

Potassium Channel
Recptor

KCNQ2/Q3 channels| KCNQ3/5| KCQN4
Research Area

Neurological Disease
Indication

——

Chemical Information

CAS Number

150812-12-7
Formula Weight

303.33
Molecular Formula

C16H18FN3O2
Purity

>98% (HPLC)
Solubility

DMSO: 10 mM
SMILES

CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.M.J. Brodie, et al. Neurology November 16, 2010 vol. 75 no. 20 1817-1824 .

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CHET3

CHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.
Tolbutamide

Tolbutamide is an inhibitor of potassium channel, used for type II diabetes.
TKIM

TKIM is a TWIK-related potassium channel 1 (TREK-1) inhibitor, binding to the pocket of the intermediate (IM) state of TREK-1.TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state.?

Sign In Join Free